{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:50:45Z","timestamp":1768283445141,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"DOI":"10.1093\/infdis\/jiy250","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T19:09:33Z","timestamp":1524769773000},"page":"886-891","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk"],"prefix":"10.1093","volume":"218","author":[{"given":"Anna E","family":"Coghill","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Bu","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Lun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei"},{"name":"Genomics Research Center, Academia Sinica, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly J","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Chu","family":"Chien","sequence":"additional","affiliation":[{"name":"Genomics Research Center, Academia Sinica, Taipei"},{"name":"National Institute of Cancer Research, National Health Research Institute, Miaoli, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei"},{"name":"Genomics Research Center, Academia Sinica, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey I","family":"Cohen","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"key\n\t\t\t\t20180814005628_CIT0001","first-page":"225","article-title":"Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups","volume":"44","author":"Henle","year":"1970","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180814005628_CIT0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"zur Hausen","year":"1970","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180814005628_CIT0003","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005628_CIT0004","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20180814005628_CIT0005","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica vaccine trial","volume":"12","author":"Kreimer","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180814005628_CIT0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180814005628_CIT0007","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"Epstein","year":"1985","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180814005628_CIT0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1099\/0022-1317-74-3-501","article-title":"Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340\/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin","volume":"74","author":"Ragot","year":"1993","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180814005628_CIT0009","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180814005628_CIT0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180814005628_CIT0011","doi-asserted-by":"crossref","first-page":"E8703","DOI":"10.1073\/pnas.1704661114","article-title":"Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies","volume":"114","author":"Sathiyamoorthy","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180814005628_CIT0012","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-Barr virus vaccines","volume":"4","author":"Cohen","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"key\n\t\t\t\t20180814005628_CIT0013","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat Microbiol"},{"key":"key\n\t\t\t\t20180814005628_CIT0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat Microbiol"},{"key":"key\n\t\t\t\t20180814005628_CIT0015","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/1078-0432.CCR-15-2299","article-title":"High levels of antibody that neutralize B-cell infection of Epstein-Barr virus and that bind EBV gp350 are associated with a lower risk of nasopharyngeal carcinoma","volume":"22","author":"Coghill","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180814005628_CIT0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180814005628_CIT0017","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180814005628_CIT0018","first-page":"1898","article-title":"Epstein-Barr virus","volume-title":"Fields virology","author":"Longenecker","year":"2013","edition":"6th ed"},{"key":"key\n\t\t\t\t20180814005628_CIT0019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.20222","article-title":"Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan","volume":"111","author":"Pickard","year":"2004","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180814005628_CIT0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JVI.65.2.996-1001.1991","article-title":"Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity","volume":"65","author":"Khyatti","year":"1991","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005628_CIT0021","doi-asserted-by":"crossref","first-page":"e01562-16","DOI":"10.1128\/JVI.01562-16","article-title":"High Epstein-Barr virus load and genomic diversity are associated with generation of gp350-specific neutralizing antibodies following acute infectious mononucleosis","volume":"91","author":"Weiss","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005628_CIT0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijc.2910480109","article-title":"Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization","volume":"48","author":"Yao","year":"1991","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180814005628_CIT0023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00674-15","article-title":"Kinetics of Epstein-Barr virus (EBV) neutralizing and virus-specific antibodies after primary infection with EBV","volume":"23","author":"Bu","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180814005628_CIT0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/cco.2016.03.20","article-title":"Therapeutic vaccination strategies to treat nasopharyngeal carcinoma","volume":"5","author":"Taylor","year":"2016","journal-title":"Chin Clin Oncol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/6\/886\/25469413\/jiy250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T09:08:57Z","timestamp":1693645737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/6\/886\/4990214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,28]]},"published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy250","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9,15]]},"published":{"date-parts":[[2018,4,28]]}}}